La Force

This research aims to explore the life experiences, needs, and expectations of family caregivers, specifically parents and siblings, of aging persons with polyhandicap aged 35 years and older. Polyhandicap is a complex chronic condition involving profound intellectual disability and serious motor impairments, leading to extreme limitations in autonomy and communication. With improved care increasing life expectancy, this study seeks to better understand the challenges faced by families as their relatives with polyhandicap age. The study uses a combined quantitative and qualitative approach involving questionnaires and interviews with parents and siblings. Data from previous evaluations of parents are already available, while sibling data will be collected through phone and mail. The research includes analysis of experiences, social views, needs, expectations, and family decision-making processes regarding support for aging individuals with polyhandicap. Participants will provide information through questionnaires and interviews lasting about 30 minutes for booklet completion and 60 minutes for interviews. The study relies on an interdisciplinary approach and a strong network of specialized centers, associations, and university teams. The main measure is the experiences of parents of aging persons with polyhandicap, and the findings aim to improve support for families during the aging transition.

Researchers are evaluating the performance and safety of a mechanical decongestant seawater spray enriched with essential oils from Laboratoires Gilbert in people aged 12 years and older who have acute rhinitis with nasal obstruction. This study focuses on cases caused by infectious episodes like rhynopharyngitis (cold), rhinosinusitis, or non-infectious episodes such as allergic rhinitis. The purpose is to assess how well the spray works and its safety over a 7-day period. Participants will use the mechanical decongestant seawater spray enriched with essential oils, and the study will track its effect on nasal obstruction symptoms. The main focus is on measuring the spray's performance from the start of treatment (Day 0) to Day 3. There are no other treatments or comparator groups mentioned. During the study, participants will complete questionnaires to provide information about their symptoms and experience. Researchers will monitor their nasal obstruction and any reactions to the spray, ensuring safety throughout. The total study duration for each participant is 7 days, with key assessments focused on the three-day mark after starting the spray.